1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Appili Therapeutics Inc.
  6. News
  7. All News
    APLI   CA03783R1073

APPILI THERAPEUTICS INC.

(APLI)
  Report
Delayed Quote. Delayed Toronto Stock Exchange - 05/20 02:59:45 pm
0.085 CAD   --.--%
05/18Appili Therapeutics Drops Near 16% as Prices $4.5 Million Offering
MT
05/18Appili Therapeutics Prices $4.5 Million Offering
MT
05/18IIROC Trade Resumption - APLI
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about APPILI THERAPEUTICS INC.
05/18Appili Therapeutics Drops Near 16% as Prices $4.5 Million Offering
MT
05/18Appili Therapeutics Prices $4.5 Million Offering
MT
05/18IIROC Trade Resumption - APLI
AQ
05/18Appili Therapeutics Announces Overnight Marketed Equity Offering
AQ
05/17IIROC Trading Halt - APLI
AQ
05/17Appili Therapeutics Details Overnight Marketed Equity Offering
MT
05/17APPILI THERAPEUTICS BRIIEF : Details Overnight Marketed Equity Offering
MT
04/27Appili Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Confe..
BU
04/13Appili Therapeutics Announces New Late-Stage Clinical Program ATI-1801 to Treat Cutaneo..
MT
04/13Appili Therapeutics Announces New Late-Stage Clinical Program ATI-1801 to Treat Cutaneo..
BU
04/13Appili Therapeutics Announces New Late-Stage Clinical Program ATI-1801 to Treat Cutaneo..
CI
03/30Appili Therapeutics Announces Non-Convertible Secured Loan of US$3.6 Million and Licens..
AQ
03/29Appili Therapeutics Announces Non-Convertible Secured Loan of US$3.6 Million, License a..
MT
03/29Appili Therapeutics Inc. Announces Non-Convertible Secured Loan of USD 3.6 Million and ..
CI
03/29Appili Therapeutics Announces License and Distribution Agreement with Long Zone Holding..
CI
03/29Appili Therapeutics Inc. announced that it expects to receive CAD 4.504032 million in f..
CI
03/09Appili Therapeutics to Present Live via Webcast at OTC Markets Virtual Life Sciences In..
AQ
02/28Appili Announces Over US$10 Million in Funding from US Defense Department for Biodefens..
MT
02/28Appili Therapeutics Announces Over US$10 Million in New Funding from US Department of D..
BU
02/28Appili Therapeutics Inc. Announces Over $10 Million in New Funding from US Department o..
CI
02/14Appili Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months..
CI
02/14Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fisc..
BU
02/08Appili Therapeutics Expands Broad-Specturm Antibiotic Commercial Agreement with Partner..
MT
02/08Appili Therapeutics Expands ATI-1501 Commercial Agreement with Partner Saptalis Pharmac..
BU
02/08Appili Therapeutics Expands ATI-1501 Commercial Agreement with Partner Saptalis Pharmac..
CI
2021Appili Therapeutics - Press Release Correction
AQ
2021Appili Therapeutics Announces Update to Funding Agreement with The Lind Partners
AQ
2021Appili Therapeutics Loses 4% as Revises Funding Agreement with The Lind Partners
MT
2021Appili Therapeutics Revises Funding Agreement with The Lind Partners
MT
2021Appili Therapeutics Announces Positive One Year Challenge Results from Preclinical Stud..
AQ
2021Appili Details "Positive" One Year Challenge Results from Preclinical Study Evaluating ..
MT
2021Appili Therapeutics Announces Positive One Year Challenge Results from Preclinical Stud..
BU
2021Appili Therapeutics Inc. Announces Positive One Year Challenge Results from Preclinical..
CI
2021Appili Therapeutics Inc. Announces Resignation of Josef Vejvoda from the Board of Direc..
CI
2021Appili Therapeutics Provides Update on Phase 3 PRESECO Clinical Trial Evaluating Avigan..
AQ
2021Appili Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months..
CI
2021Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fis..
BU
2021Appili Therapeutics Inc. Announces Executive Changes
CI
2021IIROC Trade Resumption - APLI
AQ
2021Appili Therapeutics Says Phase 3 PRESECO Clinical Trial Did Not Meet Primary Endpoint
MT
2021Appili Therapeutics Provides Update on Phase 3 PRESECO Clinical Trial Evaluating Avigan..
BU
2021Appili Therapeutics Inc. Provides Update on Phase 3 PRESECO Clinical Trial Evaluating A..
CI
2021IIROC Trading Halt - APLI
AQ
2021APPILI THERAPEUTICS : Closes Public Offering of Near $7 Million
MT
2021APPILI THERAPEUTICS : Prices Overnight Marketed Equity Offering -- Shares Down 13.5%
MT
2021APPILI THERAPEUTICS : IIROC Trade Resumption - APLI
AQ
2021APPILI THERAPEUTICS BRIEF : Prices Overnight Marketed Equity Offering
MT
2021APPILI THERAPEUTICS : IIROC Trading Halt - APLI
AQ
2021APPILI THERAPEUTICS : Announces Overnight Marketed Equity Offering
AQ
2021APPILI THERAPEUTICS : AiPharma Enters into Strategic Alliance and Stock Swap Agreement wit..
PR
2021APPILI THERAPEUTICS : AiPharma Enter Partnership, Equity Transaction
MT
2021APPILI THERAPEUTICS : and AiPharma Announce Strategic Alliance and Equity Transaction
BU
2021Appili Therapeutics Inc. and AiPharma Global Holdings LLC Announce Strategic Alliance a..
CI
2021APPILI THERAPEUTICS : Says Last Patient Enrolled in Phase 3 Trial of Oral Avigan/Reeqonus ..
MT
2021APPILI THERAPEUTICS : Announces Last Patient Enrolled in Phase 3 Trial of Oral Avigan®/Ree..
BU
2021Appili Therapeutics Announces Last Patient Enrolled in Phase 3 Trial of Oral Avigan/Ree..
CI
2021APPILI THERAPEUTICS : Announces Agreement with FUJIFILM and Funding Support for Clinical T..
AQ
2021APPILI THERAPEUTICS : Up 1% as Secures US$1 Million from FUJIFILM to Support Clinical Tria..
MT
2021APPILI THERAPEUTICS : Secures US$1 Million from FUJIFILM to Support Clinical Trials for An..
MT
2021Appili Therapeutics Announces Agreement with Fujifilm and Funding Support for Clinical ..
CI
2021APPILI THERAPEUTICS : Announces Agreement with FUJIFILM and Funding Support for Clinical T..
BU
2021Appili Therapeutics Inc. announced that it has received $1 million in funding from FUJI..
CI
2021APPILI THERAPEUTICS : Up 5% as Completes Patient Enrollment for Avigan/Reeqonus Viral Shed..
MT
2021APPILI THERAPEUTICS : Completes Patient Enrollment for Avigan/Reeqonus Viral Shedding Sub-..
MT
2021APPILI THERAPEUTICS : Announces Completion of Patient Enrollment for Avigan®/Reeqonus&trad..
BU
2021Appili Therapeutics Inc. Announces Completion of Patient Enrollment for Avigan Reeqonus..
CI
2021APPILI THERAPEUTICS : Announces Results for Resolutions at Annual General Meeting of Share..
BU
2021Appili Therapeutics Inc. Appoints Josef Vejvoda to Its Board of Directors
CI
2021APPILI THERAPEUTICS : Announces Closing of $3.5 Million Funding Agreement
AQ
2021APPILI THERAPEUTICS : Up 2.9% after Reporting Closing of $3.5 Million Funding Agreement
MT
2021Appili Therapeutics Inc. announced that it has received CAD 3.395 million in funding fr..
CI
2021APPILI THERAPEUTICS : Reports Financial and Operational Results for First Quarter of Fisca..
AQ
2021UPDATE : Appili Therapeutics Loses 1.4% as Widens Net Loss in Fiscal Q1
MT
2021APPILI THERAPEUTICS : Widens Net Loss in Fiscal Q1
MT
2021APPILI THERAPEUTICS : Reports Financial and Operational Results for First Quarter of Fisca..
BU
1  2  3Next
Upcoming event on APPILI THERAPEUTICS INC.